Aisen P. S., Gauthier S., Vellas B., Briand R., Saumier D., Laurin J., Garceau D. (2007). Alzhemed: a potential treatment for Alzheimer's disease, Curr Alzheimer Res, 4(4), 473-8.

Belleville S., Chertkow H., Gauthier S. (2007). Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment, Neuropsychology, 21(4), 458-69.

Blair M., Kertesz A., Davis-Faroque N., Hsiung G. Y., Black S. E., Bouchard R. W., Gauthier S., Guzman D. A., Hogan D. B., Rockwood K., Feldman H. (2007). Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study, Dement Geriatr Cogn Disord, 23(6), 406-15.

Burns A., Gauthier S., Perdomo C. (2007). Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease, Int J Geriatr Psychiatry, 22(8), 806-12.

Camicioli R., Gauthier S. (2007). Clinical trials in Parkinson's disease dementia and dementia with Lewy bodies, Can J Neurol Sci, 34 Suppl 1, S109-17.

Corin E., Gauthier S., Rousseau R. (2007). Le médicament, ses reliefs et ses ombres sur la scène de la clinique transculturelle, Can J Commun Ment Health, 26(2), 37-51.

Dubois B., Burn D., Goetz C., Aarsland D., Brown T., Broe G. A., Dickson D., Duyckaerts C., Cummings J., Gauthier S., Korczyn A., Lees A., Levy R., Litvan I., Mizuno Y., McKeith I. G., Olanow C. W., Poewe W., Sampaio C., Tolosa E., Emre M. (2007). Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force, Mov Disord, 22(16), 2314-24.

Dubois B., Feldman H. H., Jacova C., Dekosky S. T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P. J., Scheltens P. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria, Lancet Neurol, 6(8), 734-46.

Emre M., Aarsland D., Brown T., Burn D. J., Duyckaerts C., Mizuno Y., Broe G. A., Cummings J., Dickson D. W., Gauthier S., Goldman J., Goetz C., Korczyn A., Lees A., Levy R., Litvan I., McKeith I., Olanow W., Poewe W., Quinn N., Sampaio C., Tolosa E., Dubois B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease, Mov Disord, 22(12), 1689-707; quiz 1837.

Ferreri F., Agbokou C., Gauthier S. (2007). [Cardiovascular effects of cholinesterase inhibitors in Alzheimer's disease], Rev Neurol (Paris), 163(10), 968-74.

Gauthier S. (2007). Outcomes for assessment of symptomatic and stabilization/disease modifying drugs, Can J Neurol Sci, 34 Suppl 1, S23-6.

Gauthier S., Erkinjutti T., Rockwood K. (2007). Vascular dementia . In Ritchie C. W, Ames D., Masters. C. L. , Cummings J. & Ritchie C. W (Eds.) , TherapeuticStrategies in Dementia (pp. 273-286). Clinical Publishing.

Gauthier S., Juby A., Rehel B., Schecter R. (2007). EXACT: rivastigmine improves the high prevalence of attention deficits and mood and behaviour symptoms in Alzheimer's disease, Int J Clin Pract, 61(6), 886-95.

Gauthier S., Poirier J. (2007). Survol des facteurs génétiques et de quelques enjeux éthiquers liés à la maladie d’Alzheimer, L’Observatoire de la génétique, www.ircm.qc.ca/bioéthique/obsgenetique, Fev/Mars.

Gauthier S., Poirier J. (2007). Maladie d’Alzheimer . In Arcand M. & Hébert R. (Eds.) , Précis de Gériatrie (pp. 257-266). Edisem Inc..

Gauthier S., Thal L. L., Rossor M. N. (2007). Future diagnosis and management of Alzheimer’s disease . In Gauthier S. (Ed.) , Clinical Diagnosis and Management of Alzheimer’s Disease (pp. 379-382). Informa Health Care.

Herrmann N., Gauthier S., Lysy P. G. (2007). Clinical practice guidelines for severe Alzheimer's disease, Alzheimer's Demen, 3(4), 385-397.

Peters K. R., Rockwood K., Black S. E., Hogan D. B., Gauthier S., Loy-English I., Hsiung G. Y., Jacova C., Kertesz A., Feldman H. H. (2007). Neuropsychiatric Symptom Clusters and Functional Disability in Cognitively-Impaired-Not-Demented Individuals, Am J Geriatr Psychiatry.

Rockwood K., Moorhouse P. K., Song X., MacKnight C., Gauthier S., Kertesz A., Montgomery P., Black S., Hogan D. B., Guzman A., Bouchard R., Feldman H. (2007). Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study, J Neurol Sci, 252(2), 106-12.

Seow D., Gauthier S. (2007). Pharmacotherapy of Alzheimer disease, Can J Psychiatry, 52(10), 620-9.